INEXAS: A Phase 2 Randomized Trial of On-demand Inhaled Interferon Beta-1a in Severe Asthmatics.

Clin Exp Allergy · 2021 · PMC7984268 · PMID 33091192

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Further analyses of these, based on biomarker quartile level, showed an increase in mPEF treatment response across subgroups of low, mid and high eosinophil levels, while there was a decreasing trend in mPEF treatment response across subgroups of low, mid and high IL‐18 levels (Table 5 and Figure 6A‐B ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.